Intellia Therapeutics, Inc. Assets, Current
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $527.83M.
- 2026-03-31: Assets, Current $466.45M.
- 2025-12-31: Assets, Current $527.71M.
- 2025-09-30: Assets, Current $581.94M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $527.83M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $466.45M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $527.71M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $581.94M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $495.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $551.39M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $639.86M 10-K · filed 2026-02-26 |
| 2024-09-30 | $710.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $757.21M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $884.04M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $998.33M 10-K · filed 2025-02-27 |
| 2023-09-30 | $893.49M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $939.62M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $963.67M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $1.22B 10-K · filed 2024-02-22 |
| 2022-09-30 | $858.95M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $895.43M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $875.37M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $769.30M 10-K · filed 2023-02-23 |
| 2021-09-30 | $814.77M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $549.40M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $601.08M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $616.52M 10-K · filed 2022-02-24 |
| 2020-09-30 | $416.25M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $446.37M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $269.76M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $289.48M 10-K · filed 2021-02-26 |
| 2019-09-30 | $295.94M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $307.14M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $303.69M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $324.98M 10-K · filed 2020-02-27 |
| 2018-09-30 | $298.83M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $317.63M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $337.72M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $354.83M 10-K · filed 2019-02-27 |
| 2017-09-30 | $229.05M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $245.92M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $261.08M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $281.31M 10-K · filed 2018-03-14 |
| 2016-09-30 | $292.70M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $302.90M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $65.94M 10-Q · filed 2016-06-03 |
| 2015-12-31 | $77.63M 10-K · filed 2017-03-14 |